Filing Details
- Accession Number:
- 0001209191-15-050599
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2015-06-05 16:25:56
- Reporting Period:
- 2015-06-03
- Filing Date:
- 2015-06-05
- Accepted Time:
- 2015-06-05 16:25:56
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1197023 | S Joshua Boger | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2015-06-03 | 1,300 | $17.16 | 346,584 | No | 4 | M | Direct | |
Common Stock | Acquisiton | 2015-06-03 | 10,400 | $35.64 | 356,984 | No | 4 | M | Direct | |
Common Stock | Disposition | 2015-06-03 | 2,600 | $124.91 | 354,384 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-03 | 6,160 | $125.80 | 348,224 | No | 4 | S | Direct | |
Common Stock | Disposition | 2015-06-03 | 2,940 | $126.63 | 345,284 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (right to buy) | Disposition | 2015-06-03 | 1,300 | $0.00 | 1,300 | $17.16 |
Common Stock | Stock Option (right to buy) | Disposition | 2015-06-03 | 10,400 | $0.00 | 10,400 | $35.64 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
8,300 | 2015-07-19 | No | 4 | M | Direct | |
354,400 | 2016-02-01 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 13,286 | Indirect | 401(k) |
Common Stock | 122,700 | Indirect | Common Stock held in trust |
Footnotes
- Transaction made pursuant to Dr. Boger's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $124.91 (range $124.42 to $125.20).
- Dr. Boger undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $125.80 (range $125.28 to $126.27).
- Open market sales reported on this line occurred at a weighted average price of $126.63 (range $126.28 to $126.93).
- Common stock held in grantor retained annuity trusts.
- Fully vested.